𝔖 Bobbio Scriptorium

✦ LIBER ✦

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

✍ Scribed by Stephan Windecker; Patrick W Serruys; Simon Wandel; Pawel Buszman; Stanislaw Trznadel; Axel Linke; Karsten Lenk; Thomas Ischinger; Volker Klauss; Franz Eberli; Roberto Corti; William Wijns; Marie-Claude Morice; Carlo di Mario; Simon Davies; Robert-Jan van Geuns; Pedro Eerdmans; Gerrit-Anne van Es; Bernhard Meier; Peter Jüni

Book ID: 117303460
Publisher: The Lancet
Year: 2008
Tongue: English
Weight: 227 KB
Volume: 372
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(08)61244-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SIROLIMUS ELUTING STENT WITH BIODEGRADAB

SIROLIMUS ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS ELUTING STENT WITH DURABLE POLYMER FOR THE TREATMENT OF PATIENTS WITH DE NOVO CORONARY ARTERY LESIONS (EVOLUTION): A RANDOMIZED NON-INFERIORITY TRIAL

✍ Junbo Ge; Lei Ge; Juying Qian; Guosheng Fu; Huiliang Liu; Genshan Ma; Yitong Ma; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Long-term clinical outcomes of biodegrad

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

✍ Giulio G Stefanini; Bindu Kalesan; Patrick W Serruys; Dik Heg; Pawel Buszman; Ax 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 286 KB

TCT-373: Impact of Diabetes on Angiograp

TCT-373: Impact of Diabetes on Angiographic And Clinical Outcomes of Revascularization With Biolimus-eluting Stent With Biodegradable Polymer and Sirolimus-eluting Stent With Durable Polymer. LEADERS Trial Substudy

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 211 KB

TCT-275: Three Year Outcomes Of Chronic

TCT-275: Three Year Outcomes Of Chronic Total Occlusion Treatment With Biolimus Eluting Biodegradable Polymer Stent Versus Sirolimus Eluting Permanent Polymer Stent In the LEADERS All-comers Trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 257 KB

TCT-569 5-year Clinical Outcomes of Biod

TCT-569 5-year Clinical Outcomes of Biodegradable Polymer Biolimus-eluting Stents versus Durable Polymer Sirolimus-eluting Stents in Patients with and without Diabetes Mellitus: a LEADERS Sub-study

✍ Axel Linke; Paweł Buszman; Patrick Serruys; Thomas Ischinger; Diethmar Antoni; V 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 211 KB

TCT-36: LEADERS: 3-Year Follow-Up from a

TCT-36: LEADERS: 3-Year Follow-Up from a Prospective, Randomized Trial of Biolimus A9-Eluting Stents with a Bioabsorbable Polymer vs. Sirolimus-Eluting Stents with a Durable Polymer

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 146 KB